246 related articles for article (PubMed ID: 16170362)
21. Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration.
Cui X; Kim HJ; Kuiatse I; Kim H; Brown PH; Lee AV
Cancer Res; 2006 May; 66(10):5304-13. PubMed ID: 16707456
[TBL] [Abstract][Full Text] [Related]
22. The three transforming regions of SV40 T antigen are required for immortalization of primary mouse embryo fibroblasts.
Conzen SD; Cole CN
Oncogene; 1995 Dec; 11(11):2295-302. PubMed ID: 8570180
[TBL] [Abstract][Full Text] [Related]
23. Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals.
Esposito DL; Blakesley VA; Koval AP; Scrimgeour AG; LeRoith D
Endocrinology; 1997 Jul; 138(7):2979-88. PubMed ID: 9202243
[TBL] [Abstract][Full Text] [Related]
24. The role of Grb2 in the growth and transformation of mouse embryo cells.
D'Ambrosio C; Hongo A; Li S; Baserga R
Oncogene; 1996 Jan; 12(2):371-8. PubMed ID: 8570214
[TBL] [Abstract][Full Text] [Related]
25. Association of insulin receptor substrate 1 with simian virus 40 large T antigen.
Fei ZL; D'Ambrosio C; Li S; Surmacz E; Baserga R
Mol Cell Biol; 1995 Aug; 15(8):4232-39. PubMed ID: 7542742
[TBL] [Abstract][Full Text] [Related]
26. Role of estrogen receptor alpha in modulating IGF-I receptor signaling and function in breast cancer.
Surmacz E; Bartucci M
J Exp Clin Cancer Res; 2004 Sep; 23(3):385-94. PubMed ID: 15595626
[TBL] [Abstract][Full Text] [Related]
27. Activation of the IGF-IR system contributes to malignant growth of human and mouse medulloblastomas.
Wang JY; Del Valle L; Gordon J; Rubini M; Romano G; Croul S; Peruzzi F; Khalili K; Reiss K
Oncogene; 2001 Jun; 20(29):3857-68. PubMed ID: 11439349
[TBL] [Abstract][Full Text] [Related]
28. The role of insulin receptor substrate-1 in transformation by v-src.
Sun H; Baserga R
J Cell Physiol; 2008 Jun; 215(3):725-32. PubMed ID: 18064649
[TBL] [Abstract][Full Text] [Related]
29. Disruption of insulin-like growth factor-1 signaling and down-regulation of cdc2 by SC-alphaalphadelta9, a novel small molecule antisignaling agent identified in a targeted array library.
Vogt A; Rice RL; Settineri CE; Yokokawa F; Yokokawa S; Wipf P; Lazo JS
J Pharmacol Exp Ther; 1998 Nov; 287(2):806-13. PubMed ID: 9808713
[TBL] [Abstract][Full Text] [Related]
30. Co-operation of simian virus 40 T antigen and insulin receptor substrate-1 in protection from apoptosis induced by interleukin-3 withdrawal.
Zhou-Li F; Xu SQ; Dews M; Baserga R
Oncogene; 1997 Aug; 15(8):961-70. PubMed ID: 9285691
[TBL] [Abstract][Full Text] [Related]
31. Sequential phosphorylation of insulin receptor substrate-2 by glycogen synthase kinase-3 and c-Jun NH2-terminal kinase plays a role in hepatic insulin signaling.
Sharfi H; Eldar-Finkelman H
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E307-15. PubMed ID: 18029441
[TBL] [Abstract][Full Text] [Related]
32. Insulin-like growth factor I receptor signaling system in JC virus T antigen-induced primitive neuroectodermal tumors--medulloblastomas.
Del Valle L; Wang JY; Lassak A; Peruzzi F; Croul S; Khalili K; Reiss K
J Neurovirol; 2002 Dec; 8 Suppl 2():138-47. PubMed ID: 12491166
[TBL] [Abstract][Full Text] [Related]
33. Sensitivity of breast cancer cell lines to the novel insulin-like growth factor-1 receptor (IGF-1R) inhibitor NVP-AEW541 is dependent on the level of IRS-1 expression.
Mukohara T; Shimada H; Ogasawara N; Wanikawa R; Shimomura M; Nakatsura T; Ishii G; Park JO; Jänne PA; Saijo N; Minami H
Cancer Lett; 2009 Sep; 282(1):14-24. PubMed ID: 19345478
[TBL] [Abstract][Full Text] [Related]
34. Nuclear translocation of insulin receptor substrate-1 by the simian virus 40 T antigen and the activated type 1 insulin-like growth factor receptor.
Prisco M; Santini F; Baffa R; Liu M; Drakas R; Wu A; Baserga R
J Biol Chem; 2002 Aug; 277(35):32078-85. PubMed ID: 12063262
[TBL] [Abstract][Full Text] [Related]
35. Aberrant intracellular IGF-1R beta-subunit makes receptor knockout cells (IGF1R-/-) susceptible to oncogenic transformation.
Natalishvili N; Axelson M; Girnita L; Larsson O; Vasilcanu D
Exp Cell Res; 2009 May; 315(8):1458-67. PubMed ID: 19302825
[TBL] [Abstract][Full Text] [Related]
36. Increased IRS-2 content and activation of IGF-I pathway contribute to enhance beta-cell mass in fetuses from undernourished pregnant rats.
Fernández E; Martín MA; Fajardo S; Escrivá F; Alvarez C
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E187-95. PubMed ID: 16912057
[TBL] [Abstract][Full Text] [Related]
37. Nitric oxide mediates the survival action of IGF-1 and insulin in pancreatic beta cells.
Cahuana GM; Tejedo JR; Hmadcha A; Ramírez R; Cuesta AL; Soria B; Martin F; Bedoya FJ
Cell Signal; 2008 Feb; 20(2):301-10. PubMed ID: 18023142
[TBL] [Abstract][Full Text] [Related]
38. Nuclear translocation of insulin receptor substrate-1 by the insulin receptor in mouse embryo fibroblasts.
Wu A; Sciacca L; Baserga R
J Cell Physiol; 2003 Jun; 195(3):453-60. PubMed ID: 12704655
[TBL] [Abstract][Full Text] [Related]
39. Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor.
Hongo A; D'Ambrosio C; Miura M; Morrione A; Baserga R
Oncogene; 1996 Mar; 12(6):1231-8. PubMed ID: 8649825
[TBL] [Abstract][Full Text] [Related]
40. ETV6-NTRK3 transformation requires insulin-like growth factor 1 receptor signaling and is associated with constitutive IRS-1 tyrosine phosphorylation.
Morrison KB; Tognon CE; Garnett MJ; Deal C; Sorensen PH
Oncogene; 2002 Aug; 21(37):5684-95. PubMed ID: 12173038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
